In an article on the rise in employee overtime pay lawsuits, Littler’s Lee Schreter discusses the possible implications of the U.S. Supreme Court’s decision in Christopher v. SmithKline. She explains that if the Court rules that pharmaceutical sales reps in this case are not exempt outside salespersons and the other exemptions are also rejected, that the result could be a dramatic financial impact on pharma companies and could change the structure of the industry.

View Article